APA (7th ed.) Citation

M, M., Z, A., Z, G., B, K., V, P., A, T., . . . C, L. (2022). Consensus statement on enzyme replacement therapy for mucopolysaccharidosis IVA in Central and South-Eastern European countries. Orphanet journal of rare diseases, 17(1), 190. https://doi.org/10.1186/s13023-022-02332-7

Chicago Style (17th ed.) Citation

M, Magner, Almássy Z, Gucev Z, Kieć-Wilk B, Plaiasu V, Tylki-Szymańska A, Zafeiriou D, Zaganas I, and Lampe C. "Consensus Statement on Enzyme Replacement Therapy for Mucopolysaccharidosis IVA in Central and South-Eastern European Countries." Orphanet Journal of Rare Diseases 17, no. 1 (2022): 190. https://doi.org/10.1186/s13023-022-02332-7.

MLA (9th ed.) Citation

M, Magner, et al. "Consensus Statement on Enzyme Replacement Therapy for Mucopolysaccharidosis IVA in Central and South-Eastern European Countries." Orphanet Journal of Rare Diseases, vol. 17, no. 1, 2022, p. 190, https://doi.org/10.1186/s13023-022-02332-7.